Replies to post #225265 on Biotech Values

[caravon]

"The market" reaction was even more overblown as if ENTA's trial was a total failure. Since there is no competition, any positive results can be judged as a success.

Some people are trying to compare the ENTA data with the failed J&J Ph3 trial. Keep in mind that these drugs are not the same.

[DewDiligence]

ENTA—EDP-938 oral presentation at IDWeek* on 10/3/19:

https://www.enanta.com/investors/news-releases/press-release/2019/New-Data-from-Enantas-Phase-2a-Human-Challenge-Study-of-EDP-938-for-RSV-to-be-Presented-at-IDWeek-2019/default.aspx

https://www.idsociety.org/events2/events/2019/October/idweek-2019/

*Conference sponsored by Infectious Diseases Society of America (IDSA).